List of Tables
    Table 1. Small Molecule Active Pharmaceutical Ingredient CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Small Molecule Active Pharmaceutical Ingredient Market Trends
    Table 3. Small Molecule Active Pharmaceutical Ingredient Market Drivers
    Table 4. Small Molecule Active Pharmaceutical Ingredient Market Challenges
    Table 5. Small Molecule Active Pharmaceutical Ingredient Market Restraints
    Table 6. Global Small Molecule Active Pharmaceutical Ingredient Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Small Molecule Active Pharmaceutical Ingredient Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Small Molecule Active Pharmaceutical Ingredient Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Small Molecule Active Pharmaceutical Ingredient Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Small Molecule Active Pharmaceutical Ingredient Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Small Molecule Active Pharmaceutical Ingredient Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Small Molecule Active Pharmaceutical Ingredient Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturer, (MT), 2017-2022
    Table 14. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Manufacturer, 2017-2022
    Table 15. Global Small Molecule Active Pharmaceutical Ingredient Price by Manufacturer (2017-2022) & (USD/MT)
    Table 16. Global Small Molecule Active Pharmaceutical Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Small Molecule Active Pharmaceutical Ingredient by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Active Pharmaceutical Ingredient as of 2021)
    Table 18. Top Players of Small Molecule Active Pharmaceutical Ingredient in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Type
    Table 20. Date of International Manufacturers Enter into Small Molecule Active Pharmaceutical Ingredient Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Small Molecule Active Pharmaceutical Ingredient Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Small Molecule Active Pharmaceutical Ingredient Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Small Molecule Active Pharmaceutical Ingredient Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Small Molecule Active Pharmaceutical Ingredient Sales by Players, (MT), 2020, 2021 & 2022
    Table 26. United States Small Molecule Active Pharmaceutical Ingredient Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Small Molecule Active Pharmaceutical Ingredient Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Small Molecule Active Pharmaceutical Ingredient Sales in Volume by Region (2017-2022) & (MT)
    Table 29. Global Small Molecule Active Pharmaceutical Ingredient Sales in Volume Forecast by Region (2023-2028) & (MT)
    Table 30. Global Small Molecule Active Pharmaceutical Ingredient Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Small Molecule Active Pharmaceutical Ingredient Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Small Molecule Active Pharmaceutical Ingredient Sales in Volume by Country (2017-2028) & (MT)
    Table 33. North America Small Molecule Active Pharmaceutical Ingredient Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales in Volume by Region (2017-2028) & (MT)
    Table 35. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Small Molecule Active Pharmaceutical Ingredient Sales in Volume by Country (2017-2028) & (MT)
    Table 37. Europe Small Molecule Active Pharmaceutical Ingredient Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Small Molecule Active Pharmaceutical Ingredient Sales in Volume by Country (2017-2028) & (MT)
    Table 39. Latin Americaa Small Molecule Active Pharmaceutical Ingredient Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales in Volume by Country (2017-2028) & (MT)
    Table 41. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Johnson Matthey Corporation Information
    Table 43. Johnson Matthey Description and Business Overview
    Table 44. Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 45. Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Product
    Table 46. Johnson Matthey Recent Development
    Table 47. Siegfried Holding AG Corporation Information
    Table 48. Siegfried Holding AG Description and Business Overview
    Table 49. Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 50. Siegfried Holding AG Product
    Table 51. Siegfried Holding AG Recent Development
    Table 52. Pfizer Corporation Information
    Table 53. Pfizer Description and Business Overview
    Table 54. Pfizer Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 55. Pfizer Product
    Table 56. Pfizer Recent Development
    Table 57. Sanofi S.A. Corporation Information
    Table 58. Sanofi S.A. Description and Business Overview
    Table 59. Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 60. Sanofi S.A. Product
    Table 61. Sanofi S.A. Recent Development
    Table 62. Novartis AG, Corporation Information
    Table 63. Novartis AG, Description and Business Overview
    Table 64. Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. Novartis AG, Product
    Table 66. Novartis AG, Recent Development
    Table 67. Bristol-Myers Squibb Corporation Information
    Table 68. Bristol-Myers Squibb Description and Business Overview
    Table 69. Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 70. Bristol-Myers Squibb Product
    Table 71. Bristol-Myers Squibb Recent Development
    Table 72. Boehringer Ingelheim GmbH Corporation Information
    Table 73. Boehringer Ingelheim GmbH Description and Business Overview
    Table 74. Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 75. Boehringer Ingelheim GmbH Product
    Table 76. Boehringer Ingelheim GmbH Recent Development
    Table 77. GlaxoSmithKline Corporation Information
    Table 78. GlaxoSmithKline Description and Business Overview
    Table 79. GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 80. GlaxoSmithKline Product
    Table 81. GlaxoSmithKline Recent Development
    Table 82. Albany Molecular Research Inc. Corporation Information
    Table 83. Albany Molecular Research Inc. Description and Business Overview
    Table 84. Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 85. Albany Molecular Research Inc. Product
    Table 86. Albany Molecular Research Inc. Recent Development
    Table 87. Bachem Holding AG Corporation Information
    Table 88. Bachem Holding AG Description and Business Overview
    Table 89. Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 90. Bachem Holding AG Product
    Table 91. Bachem Holding AG Recent Development
    Table 92. PCAS Corporation Information
    Table 93. PCAS Description and Business Overview
    Table 94. PCAS Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 95. PCAS Product
    Table 96. PCAS Recent Development
    Table 97. Patheon N.V. Corporation Information
    Table 98. Patheon N.V. Description and Business Overview
    Table 99. Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 100. Patheon N.V. Product
    Table 101. Patheon N.V. Recent Development
    Table 102. AstraZeneca Corporation Information
    Table 103. AstraZeneca Description and Business Overview
    Table 104. AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 105. AstraZeneca Product
    Table 106. AstraZeneca Recent Development
    Table 107. Johnson & Johnson Corporation Information
    Table 108. Johnson & Johnson Description and Business Overview
    Table 109. Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 110. Johnson & Johnson Product
    Table 111. Johnson & Johnson Recent Development
    Table 112. Merck & Co Corporation Information
    Table 113. Merck & Co Description and Business Overview
    Table 114. Merck & Co Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 115. Merck & Co Product
    Table 116. Merck & Co Recent Development
    Table 117. BASF SE Corporation Information
    Table 118. BASF SE Description and Business Overview
    Table 119. BASF SE Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 120. BASF SE Product
    Table 121. BASF SE Recent Development
    Table 122. Catalent Inc. Corporation Information
    Table 123. Catalent Inc. Description and Business Overview
    Table 124. Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 125. Catalent Inc. Product
    Table 126. Catalent Inc. Recent Development
    Table 127. Teva Pharmaceuticals Corporation Information
    Table 128. Teva Pharmaceuticals Description and Business Overview
    Table 129. Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 130. Teva Pharmaceuticals Product
    Table 131. Teva Pharmaceuticals Recent Development
    Table 132. Roche Corporation Information
    Table 133. Roche Description and Business Overview
    Table 134. Roche Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 135. Roche Product
    Table 136. Roche Recent Development
    Table 137. Cambrex Corporation Corporation Information
    Table 138. Cambrex Corporation Description and Business Overview
    Table 139. Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 140. Cambrex Corporation Product
    Table 141. Cambrex Corporation Recent Development
    Table 142. GILEAD Science Inc. Corporation Information
    Table 143. GILEAD Science Inc. Description and Business Overview
    Table 144. GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 145. GILEAD Science Inc. Product
    Table 146. GILEAD Science Inc. Recent Development
    Table 147. Key Raw Materials Lists
    Table 148. Raw Materials Key Suppliers Lists
    Table 149. Small Molecule Active Pharmaceutical Ingredient Customers List
    Table 150. Small Molecule Active Pharmaceutical Ingredient Distributors List
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Small Molecule Active Pharmaceutical Ingredient Product Picture
    Figure 2. Global Small Molecule Active Pharmaceutical Ingredient Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Small Molecule Active Pharmaceutical Ingredient Market Size 2017-2028 (US$ Million)
    Figure 4. Global Small Molecule Active Pharmaceutical Ingredient Sales 2017-2028 (MT)
    Figure 5. United States Small Molecule Active Pharmaceutical Ingredient Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Small Molecule Active Pharmaceutical Ingredient Market Size 2017-2028 (US$ Million)
    Figure 7. United States Small Molecule Active Pharmaceutical Ingredient Sales 2017-2028 (MT)
    Figure 8. United States Small Molecule Active Pharmaceutical Ingredient Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Small Molecule Active Pharmaceutical Ingredient Market Share in Global, in Volume (MT) 2017-2028
    Figure 10. Small Molecule Active Pharmaceutical Ingredient Report Years Considered
    Figure 11. Product Picture of Standard API
    Figure 12. Product Picture of High Potency API
    Figure 13. Global Small Molecule Active Pharmaceutical Ingredient Market Share by Type in 2022 & 2028
    Figure 14. Global Small Molecule Active Pharmaceutical Ingredient Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Small Molecule Active Pharmaceutical Ingredient Sales by Type (2017-2028) & (MT)
    Figure 17. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Small Molecule Active Pharmaceutical Ingredient Price by Type (2017-2028) & (USD/MT)
    Figure 19. United States Small Molecule Active Pharmaceutical Ingredient Market Share by Type in 2022 & 2028
    Figure 20. United States Small Molecule Active Pharmaceutical Ingredient Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Small Molecule Active Pharmaceutical Ingredient Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Small Molecule Active Pharmaceutical Ingredient Sales by Type (2017-2028) & (MT)
    Figure 23. United States Small Molecule Active Pharmaceutical Ingredient Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Small Molecule Active Pharmaceutical Ingredient Price by Type (2017-2028) & (USD/MT)
    Figure 25. Product Picture of Cardiovascular Diseases
    Figure 26. Product Picture of Respiratory Disorders
    Figure 27. Product Picture of Infectious Diseases
    Figure 28. Product Picture of Others
    Figure 29. Global Small Molecule Active Pharmaceutical Ingredient Market Share by Application in 2022 & 2028
    Figure 30. Global Small Molecule Active Pharmaceutical Ingredient Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Small Molecule Active Pharmaceutical Ingredient Sales by Application (2017-2028) & (MT)
    Figure 33. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Small Molecule Active Pharmaceutical Ingredient Price by Application (2017-2028) & (USD/MT)
    Figure 35. United States Small Molecule Active Pharmaceutical Ingredient Market Share by Application in 2022 & 2028
    Figure 36. United States Small Molecule Active Pharmaceutical Ingredient Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Small Molecule Active Pharmaceutical Ingredient Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Small Molecule Active Pharmaceutical Ingredient Sales by Application (2017-2028) & (MT)
    Figure 39. United States Small Molecule Active Pharmaceutical Ingredient Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Small Molecule Active Pharmaceutical Ingredient Price by Application (2017-2028) & (USD/MT)
    Figure 41. North America Small Molecule Active Pharmaceutical Ingredient Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 42. North America Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Small Molecule Active Pharmaceutical Ingredient Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 46. Europe Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 53. Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Small Molecule Active Pharmaceutical Ingredient Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 65. Latin America Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 70. Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Small Molecule Active Pharmaceutical Ingredient Value Chain
    Figure 75. Small Molecule Active Pharmaceutical Ingredient Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed